Greiner Bio-One Launches New Safety Blood Collection Set
By LabMedica International staff writers Posted on 25 Jun 2018 |
Image: The VACUETTE SAFETY Winged Set (Photo courtesy of Greiner Bio-One).
Greiner Bio-One (Kremsmünster, Austria) has made a new addition to its range of safety products and now offers its customers an even wider selection of safety blood collection sets with the launch of the VACUETTE SAFETY Winged Set.
Approximately one-third of all occupational incidents in healthcare involve needlestick injuries. Nurses are particularly at a risk of being infected by blood-borne diseases such as hepatitis B, hepatitis C and HIV. The use safety products for taking blood samples lowers the risk of needlestick injuries.
Greiner Bio One develops, manufactures, and supplies specimen collection systems, and products for pharmaceutical substance screening. The company offers pre-analytical products for collecting and processing human samples, including venous and capillary blood collection systems, urine collection systems, blood collection systems for neonates and infants, safety products, accessories, transport lines, disposals, instruments, saliva collection and quantification systems, and others.
In response to the demand for its safety products, Greiner Bio One has expanded its existing range with the launch of the new VACUETTE SAFETY Winged Set. Each of the VACUETTE SAFETY Winged Sets is equipped with a safety mechanism, which offers three different options for activating it immediately after blood collection. The safety mechanism makes a clearly audible click to confirm that the needle is safely and irreversibly locked in the safety shield. In order to provide users with more choice, the safety blood collection set is available both with and without a pre-assembled blood culture holder. Additionally, its transparent product design provides optimal blood flow visibility.
Approximately one-third of all occupational incidents in healthcare involve needlestick injuries. Nurses are particularly at a risk of being infected by blood-borne diseases such as hepatitis B, hepatitis C and HIV. The use safety products for taking blood samples lowers the risk of needlestick injuries.
Greiner Bio One develops, manufactures, and supplies specimen collection systems, and products for pharmaceutical substance screening. The company offers pre-analytical products for collecting and processing human samples, including venous and capillary blood collection systems, urine collection systems, blood collection systems for neonates and infants, safety products, accessories, transport lines, disposals, instruments, saliva collection and quantification systems, and others.
In response to the demand for its safety products, Greiner Bio One has expanded its existing range with the launch of the new VACUETTE SAFETY Winged Set. Each of the VACUETTE SAFETY Winged Sets is equipped with a safety mechanism, which offers three different options for activating it immediately after blood collection. The safety mechanism makes a clearly audible click to confirm that the needle is safely and irreversibly locked in the safety shield. In order to provide users with more choice, the safety blood collection set is available both with and without a pre-assembled blood culture holder. Additionally, its transparent product design provides optimal blood flow visibility.
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance